Chemotherapy for Gynecologic Malignancies
- Targeted therapies such as antiangiogenesis agents improve outcomes in ovarian and metastatic cervical cancer.
- Poly(ADP)ribose polymerase (PARP) inhibitors improve outcomes as treatment and maintenance therapies in recurrent epithelial ovarian cancer.
- Intraperitoneal administration of chemotherapy can be considered for a select group of patients with ovarian cancer in the front-line setting.








.png)







